Thoracic Radiotherapy for Mediastinal Nodal Recurrence

Thoracic Radiotherapy for Mediastinal Nodal Recurrence

Radiotherapy has been used to treat loco-regional recurrences located at various intra-thoracic sites, but longterm survival of these patients has been rarely observed. We report herein a lung adenocarcinoma patient with locoregional recurrence, who was successfully treated with high-dose radiothera...

Full description

Bibliographic Details
Main Authors: Katsunori Kagohashi, Hidetsugu Nakayama, Kenji Kagei, Koichi Kurishima, Hiroichi Ishikawa, Hiroaki Satoh
Format: Article
Language:English
Published: Karolinum Press 2009-01-01
Series:Acta Medica
Subjects:
Non-small cell lung cancer
Loco-regional recurrence
Radiotherapy
Online Access:https://actamedica.lfhk.cuni.cz/52/1/0023/
id doaj-6d87f6548fa34723a219eb9c3bc73409
record_format Article
spelling doaj-6d87f6548fa34723a219eb9c3bc734092020-11-24T23:28:49ZengKarolinum PressActa Medica1211-42861805-96942009-01-01521232510.14712/18059694.2016.103Thoracic Radiotherapy for Mediastinal Nodal RecurrenceKatsunori Kagohashi0Hidetsugu Nakayama1Kenji Kagei2Koichi Kurishima3Hiroichi Ishikawa4Hiroaki Satoh5University of Tsukuba, Institute of Clinical Medicine, Division of Respiratory Medicine, Tsubaka-city, Ibaraki, 305–8575, JapanUniversity of Tsukuba, Institute of Clinical Medicine, Department of Radiation Oncology, Tsubaka-city, Ibaraki, 305–8575, JapanUniversity of Tsukuba, Institute of Clinical Medicine, Department of Radiation Oncology, Tsubaka-city, Ibaraki, 305–8575, JapanUniversity of Tsukuba, Institute of Clinical Medicine, Division of Respiratory Medicine, Tsubaka-city, Ibaraki, 305–8575, JapanUniversity of Tsukuba, Institute of Clinical Medicine, Division of Respiratory Medicine, Tsubaka-city, Ibaraki, 305–8575, JapanUniversity of Tsukuba, Institute of Clinical Medicine, Division of Respiratory Medicine, Tsubaka-city, Ibaraki, 305–8575, JapanRadiotherapy has been used to treat loco-regional recurrences located at various intra-thoracic sites, but longterm survival of these patients has been rarely observed. We report herein a lung adenocarcinoma patient with locoregional recurrence, who was successfully treated with high-dose radiotherapy. The patient could survive with no evidence of recurrence 5 years after thoracic irradiation. It is probably safe to administrate high-dose radiotherapy for some loco-regional recurrent patients with favorable prognostic factors such as good PS, no body weight loss. Further studies will be required to define a favorable subset of patients most likely to benefit from an aggressive approach.https://actamedica.lfhk.cuni.cz/52/1/0023/Non-small cell lung cancerLoco-regional recurrenceRadiotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Katsunori Kagohashi
Hidetsugu Nakayama
Kenji Kagei
Koichi Kurishima
Hiroichi Ishikawa
Hiroaki Satoh
spellingShingle Katsunori Kagohashi
Hidetsugu Nakayama
Kenji Kagei
Koichi Kurishima
Hiroichi Ishikawa
Hiroaki Satoh
Thoracic Radiotherapy for Mediastinal Nodal Recurrence
Acta Medica
Non-small cell lung cancer
Loco-regional recurrence
Radiotherapy
author_facet Katsunori Kagohashi
Hidetsugu Nakayama
Kenji Kagei
Koichi Kurishima
Hiroichi Ishikawa
Hiroaki Satoh
author_sort Katsunori Kagohashi
title Thoracic Radiotherapy for Mediastinal Nodal Recurrence
title_short Thoracic Radiotherapy for Mediastinal Nodal Recurrence
title_full Thoracic Radiotherapy for Mediastinal Nodal Recurrence
title_fullStr Thoracic Radiotherapy for Mediastinal Nodal Recurrence
title_full_unstemmed Thoracic Radiotherapy for Mediastinal Nodal Recurrence
title_sort thoracic radiotherapy for mediastinal nodal recurrence
publisher Karolinum Press
series Acta Medica
issn 1211-4286
1805-9694
publishDate 2009-01-01
description Radiotherapy has been used to treat loco-regional recurrences located at various intra-thoracic sites, but longterm survival of these patients has been rarely observed. We report herein a lung adenocarcinoma patient with locoregional recurrence, who was successfully treated with high-dose radiotherapy. The patient could survive with no evidence of recurrence 5 years after thoracic irradiation. It is probably safe to administrate high-dose radiotherapy for some loco-regional recurrent patients with favorable prognostic factors such as good PS, no body weight loss. Further studies will be required to define a favorable subset of patients most likely to benefit from an aggressive approach.
topic Non-small cell lung cancer
Loco-regional recurrence
Radiotherapy
url https://actamedica.lfhk.cuni.cz/52/1/0023/
work_keys_str_mv AT katsunorikagohashi thoracicradiotherapyformediastinalnodalrecurrence
AT hidetsugunakayama thoracicradiotherapyformediastinalnodalrecurrence
AT kenjikagei thoracicradiotherapyformediastinalnodalrecurrence
AT koichikurishima thoracicradiotherapyformediastinalnodalrecurrence
AT hiroichiishikawa thoracicradiotherapyformediastinalnodalrecurrence
AT hiroakisatoh thoracicradiotherapyformediastinalnodalrecurrence
_version_ 1725547911228424192

Similar Items